Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6501
    +0.0001 (+0.01%)
     

  • OIL

    82.70
    -0.11 (-0.13%)
     

  • GOLD

    2,328.10
    -10.30 (-0.44%)
     

  • Bitcoin AUD

    98,949.30
    -3,522.32 (-3.44%)
     

  • CMC Crypto 200

    1,388.36
    -35.74 (-2.51%)
     

  • AUD/EUR

    0.6072
    +0.0001 (+0.02%)
     

  • AUD/NZD

    1.0944
    +0.0002 (+0.02%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    0.00 (0.00%)
     

Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Dan Caplinger, The Motley Fool
·3-min read
Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Just as the Nasdaq Composite (NASDAQINDEX: ^IXIC) led markets lower in 2022, the index is working hard to lead a rebound early in 2023. After being the only one of the three major U.S. stock market indexes to finish higher on Tuesday, the Nasdaq once again looked good early Wednesday morning, with futures on the index rising nearly half a percent. One winner leading the Nasdaq higher Wednesday morning was vaccine stock Moderna (NASDAQ: MRNA), which announced positive news that showed investors the company is more than just a one-trick pony.

Continue reading